A Study to Evaluate the Safety and Efficacy of Icatibant in Patients With Bradykinin Induced Angioedema

Clinical trial NCT07290855 · COMPLETED

Trial details

NCT number: NCT07290855
Sponsor: Nang Kuang Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Bradykinin-mediated Angioedema Hereditary Angioedema (HAE)

Start date: 2024-09-27
Primary completion: 2025-05-27
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.